The field of epilepsy management has seen significant advancements in recent years. This article aims to provide healthcare professionals with a comprehensive update on these developments, to enhance patient care and outcomes.
New antiepileptic drugs (AEDs) have been introduced, offering improved efficacy and tolerability. These include brivaracetam, perampanel, and eslicarbazepine. Brivaracetam has shown promise in controlling focal seizures, while perampanel is effective for both focal and primary generalized tonic-clonic seizures. Eslicarbazepine offers a once-daily dosing option and fewer side effects.
Neuromodulation techniques such as Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS) have gained acceptance for drug-resistant epilepsy. VNS involves electrical stimulation of the vagus nerve, RNS monitors brain activity and delivers electrical pulses to prevent seizures, while DBS targets specific brain areas.
Minimally invasive surgical techniques, such as laser interstitial thermal therapy (LITT) and stereotactic EEG-guided radiofrequency thermocoagulation (SEEG-RFTC), have revolutionized epilepsy surgery. LITT uses laser-induced heat to ablate seizure foci, and SEEG-RFTC employs radiofrequency energy for the same purpose, both minimizing brain tissue damage.
Genomic medicine has improved our understanding of epilepsy's genetic basis, enabling personalized treatment strategies. Next-generation sequencing technologies have identified numerous epilepsy-associated genes, facilitating early diagnosis and targeted therapy.
These advancements in epilepsy management are transforming patient care, improving seizure control, and enhancing quality of life. It is crucial for healthcare professionals to stay updated with these developments to deliver optimal patient care. Further research will undoubtedly usher in more breakthroughs in this field.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation